At the time of writing, Semler Scientific Inc [SMLR] stock is trading at $25.47, down -0.82%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SMLR shares have lost -9.68% over the last week, with a monthly amount drifted -12.50%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, The Benchmark Company started tracking the stock with Buy rating on July 08, 2025, and set its price target to $101. On November 02, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $45 on the stock.
For the past year, the stock price of Semler Scientific Inc fluctuated between $23.51 and $81.56. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Semler Scientific Inc [NASDAQ: SMLR] shares were valued at $25.47 at the most recent close of the market. An investor can expect a potential return of 139.5% based on the average SMLR price forecast.
Analyzing the SMLR fundamentals
According to Semler Scientific Inc [NASDAQ:SMLR], the company’s sales were 42.98M for trailing twelve months, which represents an -43.19% plunge. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -0.57%, Pretax Profit Margin comes in at 1.04%, and Net Profit Margin reading is 0.86%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.17 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Semler Scientific Inc [NASDAQ:SMLR] has a current ratio of 0.60. In addition, the Quick Ratio stands at 0.58 and the Cash Ratio stands at 0.37. Considering the valuation of this stock, the price to sales ratio is 11.61, the price to book ratio is 0.91 and price to earnings (TTM) ratio is 10.49.
Transactions by insiders
Recent insider trading involved Murphy-Chutorian Douglas, Chief Executive Officer, that happened on Aug 25 ’25 when 28604.0 shares were sold. CEO, Douglas Murphy-Chutorian completed a deal on Aug 25 ’25 to buy 60000.0 shares. Meanwhile, CEO Murphy-Chutorian Douglas sold 75000.0 shares on Dec 10 ’24.
